Clinical manifestations of familial medullary thyroid carcinoma

Kaori Kameyama, Hiroko Okinaga, Hiroshi Takami

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

We conducted a large-scale nation-wide questionnaire survey to ascertain the status of familial medullary thyroid carcinoma (MTC) in Japan in 2002. Out of a total of 271 MTC cases (male to female ratio 1:1.4), multiple endocrine neoplasia (MEN) 2A accounted for 83 cases (30.6%), familial MTC (FMTC) for 14 cases (5.1%), MEN for 11 cases (4.1%), and sporadic MTC for 163 cases (60.1%). Mean age at the time of diagnosis was 35.6 in MEN2A, 34.6 in FMTC, 30.5 in MEN2B, and 47.6 in sporadic MTC. Forty-five percent of MEN2A patients had pheochromocytoma and 11% of MEN2A patients had parathyroid disorders when MTC was diagnosed. Finally, the RET oncogene test yielded the largest number of initial findings that led to diagnosis of familial MTC.

Original languageEnglish
Pages (from-to)348-350
Number of pages3
JournalBiomedicine and Pharmacotherapy
Volume58
Issue number6-7
DOIs
Publication statusPublished - 2004 Jun

Fingerprint

Multiple Endocrine Neoplasia
Parathyroid Diseases
Pheochromocytoma
Oncogenes
Japan
Medullary Thyroid cancer
Familial medullary thyroid carcinoma
Surveys and Questionnaires

Keywords

  • Familial cancer
  • Medullary thyroid carcinoma
  • RET protooncogene

ASJC Scopus subject areas

  • Pharmacology

Cite this

Clinical manifestations of familial medullary thyroid carcinoma. / Kameyama, Kaori; Okinaga, Hiroko; Takami, Hiroshi.

In: Biomedicine and Pharmacotherapy, Vol. 58, No. 6-7, 06.2004, p. 348-350.

Research output: Contribution to journalArticle

Kameyama, Kaori ; Okinaga, Hiroko ; Takami, Hiroshi. / Clinical manifestations of familial medullary thyroid carcinoma. In: Biomedicine and Pharmacotherapy. 2004 ; Vol. 58, No. 6-7. pp. 348-350.
@article{9a17c05093d04e2db9413fc11df71b2e,
title = "Clinical manifestations of familial medullary thyroid carcinoma",
abstract = "We conducted a large-scale nation-wide questionnaire survey to ascertain the status of familial medullary thyroid carcinoma (MTC) in Japan in 2002. Out of a total of 271 MTC cases (male to female ratio 1:1.4), multiple endocrine neoplasia (MEN) 2A accounted for 83 cases (30.6{\%}), familial MTC (FMTC) for 14 cases (5.1{\%}), MEN for 11 cases (4.1{\%}), and sporadic MTC for 163 cases (60.1{\%}). Mean age at the time of diagnosis was 35.6 in MEN2A, 34.6 in FMTC, 30.5 in MEN2B, and 47.6 in sporadic MTC. Forty-five percent of MEN2A patients had pheochromocytoma and 11{\%} of MEN2A patients had parathyroid disorders when MTC was diagnosed. Finally, the RET oncogene test yielded the largest number of initial findings that led to diagnosis of familial MTC.",
keywords = "Familial cancer, Medullary thyroid carcinoma, RET protooncogene",
author = "Kaori Kameyama and Hiroko Okinaga and Hiroshi Takami",
year = "2004",
month = "6",
doi = "10.1016/j.biopha.2004.05.002",
language = "English",
volume = "58",
pages = "348--350",
journal = "Biomedicine and Pharmacotherapy",
issn = "0753-3322",
publisher = "Elsevier Masson",
number = "6-7",

}

TY - JOUR

T1 - Clinical manifestations of familial medullary thyroid carcinoma

AU - Kameyama, Kaori

AU - Okinaga, Hiroko

AU - Takami, Hiroshi

PY - 2004/6

Y1 - 2004/6

N2 - We conducted a large-scale nation-wide questionnaire survey to ascertain the status of familial medullary thyroid carcinoma (MTC) in Japan in 2002. Out of a total of 271 MTC cases (male to female ratio 1:1.4), multiple endocrine neoplasia (MEN) 2A accounted for 83 cases (30.6%), familial MTC (FMTC) for 14 cases (5.1%), MEN for 11 cases (4.1%), and sporadic MTC for 163 cases (60.1%). Mean age at the time of diagnosis was 35.6 in MEN2A, 34.6 in FMTC, 30.5 in MEN2B, and 47.6 in sporadic MTC. Forty-five percent of MEN2A patients had pheochromocytoma and 11% of MEN2A patients had parathyroid disorders when MTC was diagnosed. Finally, the RET oncogene test yielded the largest number of initial findings that led to diagnosis of familial MTC.

AB - We conducted a large-scale nation-wide questionnaire survey to ascertain the status of familial medullary thyroid carcinoma (MTC) in Japan in 2002. Out of a total of 271 MTC cases (male to female ratio 1:1.4), multiple endocrine neoplasia (MEN) 2A accounted for 83 cases (30.6%), familial MTC (FMTC) for 14 cases (5.1%), MEN for 11 cases (4.1%), and sporadic MTC for 163 cases (60.1%). Mean age at the time of diagnosis was 35.6 in MEN2A, 34.6 in FMTC, 30.5 in MEN2B, and 47.6 in sporadic MTC. Forty-five percent of MEN2A patients had pheochromocytoma and 11% of MEN2A patients had parathyroid disorders when MTC was diagnosed. Finally, the RET oncogene test yielded the largest number of initial findings that led to diagnosis of familial MTC.

KW - Familial cancer

KW - Medullary thyroid carcinoma

KW - RET protooncogene

UR - http://www.scopus.com/inward/record.url?scp=3242692440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242692440&partnerID=8YFLogxK

U2 - 10.1016/j.biopha.2004.05.002

DO - 10.1016/j.biopha.2004.05.002

M3 - Article

C2 - 15271414

AN - SCOPUS:3242692440

VL - 58

SP - 348

EP - 350

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

SN - 0753-3322

IS - 6-7

ER -